Annual Total Debt
$623.64 M
+$521.06 M+507.94%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual total debt is currently $623.64 million, with the most recent change of +$521.06 million (+507.94%) on 31 December 2023. During the last 3 years, it has risen by +$556.37 million (+827.07%). AMPH annual total debt is now at all-time high.AMPH Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$629.85 M
+$9.27 M+1.49%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly total debt is currently $629.85 million, with the most recent change of +$9.27 million (+1.49%) on 30 September 2024. Over the past year, it has dropped by -$42.71 million (-6.35%). AMPH quarterly total debt is now -6.35% below its all-time high of $672.56 million, reached on 30 September 2023.AMPH Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +507.9% | -6.3% |
| 3 y3 years | +827.1% | +493.4% |
| 5 y5 years | +1142.0% | +867.8% |
AMPH Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +827.1% | -6.3% | +517.4% |
| 5 y | 5 years | at high | +1142.0% | -6.3% | +873.9% |
| alltime | all time | at high | -6.3% |
Amphastar Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $629.85 M(+1.5%) |
| June 2024 | - | $620.58 M(-1.0%) |
| Mar 2024 | - | $627.12 M(+0.6%) |
| Dec 2023 | $623.64 M(+507.9%) | $623.64 M(-7.3%) |
| Sept 2023 | - | $672.56 M(+27.2%) |
| June 2023 | - | $528.74 M(+418.2%) |
| Mar 2023 | - | $102.03 M(-0.5%) |
| Dec 2022 | $102.58 M(-2.0%) | $102.58 M(-0.6%) |
| Sept 2022 | - | $103.24 M(-0.7%) |
| June 2022 | - | $103.92 M(-1.3%) |
| Mar 2022 | - | $105.28 M(+0.6%) |
| Dec 2021 | $104.66 M(+55.6%) | $104.66 M(-1.4%) |
| Sept 2021 | - | $106.14 M(+60.0%) |
| June 2021 | - | $66.33 M(+2.6%) |
| Mar 2021 | - | $64.67 M(-3.9%) |
| Dec 2020 | $67.27 M(+1.0%) | $67.27 M(+1.6%) |
| Sept 2020 | - | $66.24 M(+2.4%) |
| June 2020 | - | $64.71 M(-2.8%) |
| Mar 2020 | - | $66.58 M(-0.1%) |
| Dec 2019 | $66.63 M(+32.7%) | $66.63 M(+2.4%) |
| Sept 2019 | - | $65.08 M(-3.2%) |
| June 2019 | - | $67.22 M(+7.9%) |
| Mar 2019 | - | $62.29 M(+24.1%) |
| Dec 2018 | $50.21 M | $50.21 M(-1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $51.20 M(-2.6%) |
| June 2018 | - | $52.59 M(+14.9%) |
| Mar 2018 | - | $45.77 M(-2.9%) |
| Dec 2017 | $47.16 M(+25.0%) | $47.16 M(-2.7%) |
| Sept 2017 | - | $48.44 M(+4.6%) |
| June 2017 | - | $46.31 M(+27.2%) |
| Mar 2017 | - | $36.41 M(-3.5%) |
| Dec 2016 | $37.72 M(-8.2%) | $37.72 M(-11.7%) |
| Sept 2016 | - | $42.70 M(+0.1%) |
| June 2016 | - | $42.65 M(+5.9%) |
| Mar 2016 | - | $40.27 M(-2.0%) |
| Dec 2015 | $41.10 M(-6.0%) | $41.10 M(-10.9%) |
| Sept 2015 | - | $46.12 M(-2.8%) |
| June 2015 | - | $47.43 M(-2.0%) |
| Mar 2015 | - | $48.42 M(+10.8%) |
| Dec 2014 | $43.70 M(+35.8%) | $43.70 M(-14.9%) |
| Sept 2014 | - | $51.35 M(-4.0%) |
| June 2014 | - | $53.52 M(+29.0%) |
| Mar 2014 | - | $41.50 M(+29.0%) |
| Dec 2013 | $32.17 M(-15.3%) | $32.17 M(>+9900.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00 |
| Dec 2012 | $38.00 M(>+9900.0%) | - |
| Dec 2011 | $0.00 | - |
FAQ
- What is Amphastar Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual total debt year-on-year change?
- What is Amphastar Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly total debt year-on-year change?
What is Amphastar Pharmaceuticals annual total debt?
The current annual total debt of AMPH is $623.64 M
What is the all time high annual total debt for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual total debt is $623.64 M
What is Amphastar Pharmaceuticals annual total debt year-on-year change?
Over the past year, AMPH annual total debt has changed by +$521.06 M (+507.94%)
What is Amphastar Pharmaceuticals quarterly total debt?
The current quarterly total debt of AMPH is $629.85 M
What is the all time high quarterly total debt for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly total debt is $672.56 M
What is Amphastar Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, AMPH quarterly total debt has changed by -$42.71 M (-6.35%)